NEW YORK (GenomeWeb) – Danaher today said that sales for the third quarter rose almost 7 percent year over year. 

For the three months ended Oct. 2, the company posted $5.02 billion in sales, up from $4.71 billion a year ago but short of the consensus Wall Street estimate of $5.06 billion. Danaher said that on a non-GAAP basis, core revenues grew 3 percent year over year, while acquisitions grew sales by almost 11 percent. Currency effects reduced sales by 7 percent. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.